Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of AB680 in cancer patients.

Trial Profile

Study of AB680 in cancer patients.

Phase of Trial: Phase I

Latest Information Update: 16 May 2018

At a glance

  • Drugs AB-680 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 16 May 2018 New trial record
    • 09 May 2018 According to the Arcus Biosciences media release, this trial is expected to begin in in the first half of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top